Brent Pfeiffenberger is the founder of Neogene Therapeutics. Neogene Therapeutics has raised $110M in total funding. Latest round: Series A.
Brent Pfeiffenberger is the founder of Neogene Therapeutics, a biotechnology company focused on developing personalized T-cell receptor therapies for cancer patients. He led the company's $110 million Series A financing and established a partnership with Twist Bioscience.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide